In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
486 News Items found
Andrea Barrio, a breast cancer surgeon at Memorial Sloan Kettering Cancer Center, talks to a patient
Important New Insights into Lymphedema: High Risk, Race, and Ethnicity

Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.
Christopher Klebanoff
In the Lab
New Immunotherapy Approach Targets a Commonly Mutated ‘Driver’ Protein Unique to Cancer Cells

Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer.
MSK director of social work Penny Damaskos, posing with a human-sized number 8
Feature
How Social Workers Help People with Cancer: 8 Questions with Penny Damaskos

Meet MSK Director of Social Work Penny Damaskos and learn how she and her team help people with cancer.
Claire’s Legacy
MSK Giving: Claire’s Legacy

Learn why an MSK patient is supporting the MSK mission with a bequest.
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
detail shot of a lab coat with the MSK logo
MSK Research Highlights, June 18, 2025

New MSK research finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is linked to APOBEC3 enzymes; investigates opportunities for restoring sensitivity to endocrine therapy; and finds acupuncture may help prostate cancer survivors wake up less often at night to urinate.
John Mendelsohn
Feature
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer

The scientific world lost one of its greats this week. Here, we reflect on his influence.
Woman giving presentation at work
Finding
Study Highlights Workplace Difficulties Some Women Face During Cancer Treatment

Discover the role of the work environment in the life and career of an employee with cancer.
Meryl Jacobs poses with her husband and grandkids
FDA Approves Zenocutuzumab for Pancreatic and Lung Cancers With NRG1 Fusions 

The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small cell lung cancer with an alteration called an NRG1 gene fusion, based on a phase 2 clinical trial led by an MSK investigator.
Dr. Nancy Lee, Dr. Alan Ho, and Dr. Richard Wong review scans on a computer
ASTRO 2025 Highlights From MSK

Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology.